Literature DB >> 7781734

High prevalence of antibodies to Chlamydia pneumoniae; determinants of IgG and IgA seropositivity among Jerusalem residents.

O Paltiel1, J D Kark, M Leinonen, P Saikku.   

Abstract

The prevalence of antibodies to Chlamydia pneumoniae was examined in a stratified random sample of 581 Jerusalem adult residents between August 1987 and March 1989. IgG and IgA titres were measured by microimmunofluorescence, and associations with smoking and socio-demographic variables were assessed. IgG antibodies were found in 84.5% (95% confidence interval (CI): 80.4-87.9) of men and 68.7% (95% CI: 61.6-75.0) of women (P < 0.0001 for sex difference), indicating a very high rate of exposure in this population. IgA antibodies, postulated to represent persistent infection, were present in 45.1% (95% CI: 40.1-50.2) of men and 23% (95% CI: 17.4-29.7) of women (P < 0.0001 for sex difference). Factors associated with IgG seropositivity included family size, education and social class. On the other hand age (in men) and smoking were associated with IgA seropositivity. These findings support the hypothesis that low socioeconomic status and household crowding may be predictive of exposure to or infection with this organism (IgG seropositivity), whereas they do not explain persistence of the infection putatively expressed as IgA seropositivity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7781734      PMCID: PMC2271293          DOI: 10.1017/s0950268800052171

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  24 in total

1.  Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction.

Authors:  M Leinonen; E Linnanmäki; K Mattila; M S Nieminen; V Valtonen; M Leirisalo-Repo; P Saikku
Journal:  Microb Pathog       Date:  1990-07       Impact factor: 3.738

2.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

3.  Acute lower-respiratory-tract infection associated with chlamydial TWAR antibody in Filipino children.

Authors:  P Saikku; P Ruutu; M Leinonen; J Panelius; T E Tupasi; J T Grayston
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

4.  Studies on the role of the famiy unit in the transmission of trachoma.

Authors:  J Barenfanger
Journal:  Am J Trop Med Hyg       Date:  1975-05       Impact factor: 2.345

5.  Subacute chlamydial endocarditis.

Authors:  R B Jones; J B Priest; C Kuo
Journal:  JAMA       Date:  1982-02-05       Impact factor: 56.272

Review 6.  A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.

Authors:  J T Grayston; L A Campbell; C C Kuo; C H Mordhorst; P Saikku; D H Thom; S P Wang
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

Review 7.  Chlamydial infections of the heart.

Authors:  M Odeh; A Oliven
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

8.  IgA antichlamydia antibodies as a diagnostic tool for monitoring of active chlamydial infection.

Authors:  Z Samra; Y Soffer
Journal:  Eur J Epidemiol       Date:  1992-11       Impact factor: 8.082

9.  An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci.

Authors:  P Saikku; S P Wang; M Kleemola; E Brander; E Rusanen; J T Grayston
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.

Authors:  J T Grayston; C C Kuo; S P Wang; J Altman
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245

View more
  4 in total

1.  Atherosclerosis due to chronic arteritis caused by Chlamydia pneumoniae: a tentative hypothesis.

Authors:  W Stille; R Dittmann; G Just-Nübling
Journal:  Infection       Date:  1997 Sep-Oct       Impact factor: 3.553

2.  Chlamydia pneumoniae antibodies are associated with an atherogenic lipid profile.

Authors:  L J Murray; D P O'Reilly; G M Ong; C O'Neill; A E Evans; K B Bamford
Journal:  Heart       Date:  1999-03       Impact factor: 5.994

Review 3.  [Arteriosclerosis as a sequela of chronic Chlamydia pneumoniae infection].

Authors:  W Stille; R Dittmann
Journal:  Herz       Date:  1998-05       Impact factor: 1.443

4.  Chlamydia pneumoniae and asthma.

Authors:  P J Cook; P Davies; W Tunnicliffe; J G Ayres; D Honeybourne; R Wise
Journal:  Thorax       Date:  1998-04       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.